Personal information

Countries

Congo - Kinshasa

Activities

Collapse all

Works (3)

Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial

The Lancet Infectious Diseases
2024-07 | Journal article
DOI: 10.1016/S1473-3099(24)00058-6
Contributors: Ynke Larivière; Trésor Zola Matuvanga; Bernard Isekah Osang'ir; Solange Milolo; Rachel Meta; Primo Kimbulu; Cynthia Robinson; Michael Katwere; Chelsea McLean; Gwen Lemey et al.
Source: check_circle
Crossref

Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo

The Journal of Infectious Diseases
2024-04-12 | Journal article
DOI: 10.1093/infdis/jiad350
Contributors: Ynke Larivière; Irene Garcia-Fogeda; Trésor Zola Matuvanga; Bernard Isekah Osang'ir; Solange Milolo; Rachel Meta; Primo Kimbulu; Cynthia Robinson; Michael Katwere; Chelsea McLean et al.
Source: check_circle
Crossref

Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned

Vaccine
2023-12 | Journal article
DOI: 10.1016/j.vaccine.2023.11.030
Contributors: Ynke Larivière; Trésor Zola Matuvanga; Gwen Lemey; Bernard Isekah Osang'ir; Paul Peter Vermeiren; Solange Milolo; Rachel Meta; Primo Kimbulu; Emmanuel Esanga; Junior Matangila et al.
Source: check_circle
Crossref
How many people are using ORCID?